Literature DB >> 7662375

Multiple primary lung cancers.

M Ribet1, P Dambron.   

Abstract

Seventy-five cases of multiple primary lung cancers, representing 3.78% of a series of 1980 consecutively resected tumors, were divided into 24 synchronous and 51 metachronous cancers, according to the criteria of Martini and Melamed. They all concerned tobacco-smoking men. The synchronous tumors were symptomatic in 66% of the cases, the metachronous tumors in 37%. Nine synchronous locations were unilateral and 15 were bilateral; 20 metachronous locations were ipsilateral and 31 were contralateral. There were three third metachronous cancers. The resection of both tumours was performed for 15 synchronous cancers and for 19 metachronous cancers, including two third metachronous tumors. There were two deaths related to metachronous cancers. No patient with resected synchronous cancers survived 5 years, while 20% of patients with resected metachronous cancers survived this period. Synchronous cancers appear to represent an advanced stage. Metachronous cancers are often diagnosed too late.

Entities:  

Mesh:

Year:  1995        PMID: 7662375     DOI: 10.1016/s1010-7940(05)80155-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.

Authors:  Jad Saab; Hamid Zia; Susan Mathew; Michael Kluk; Navneet Narula; Helen Fernandes
Journal:  Transl Oncol       Date:  2017-04-25       Impact factor: 4.243

2.  Characteristics and prognosis of synchronous multiple primary lung cancer after surgical treatment: A systematic review and meta-analysis of current evidence.

Authors:  Hongtao Tie; Jun Luo; Rui Shi; Zhenhan Li; Dan Chen; Qingchen Wu
Journal:  Cancer Med       Date:  2020-12-10       Impact factor: 4.452

3.  Intraoperative Diagnosis and Surgical Procedure with Imprint Cytology for Small Pulmonary Adenocarcinoma.

Authors:  Tomoyuki Nakagiri; Tomio Nakayama; Toshiteru Tokunaga; Akemi Takenaka; Hidenori Kunoh; Hiroto Ishida; Yasuhiko Tomita; Shin-Ichi Nakatsuka; Harumi Nakamura; Jiro Okami; Masahiko Higashiyama
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.